Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.

Steve Vucic1, Kristin R Black, Peter Siao Tick Chong

  • 1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Neurology
|October 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

F-waves in primary lateral sclerosis: a window into spinal motoneuron hyperexcitability.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Muscle Ultrasound Is a Sensitive Outcome Measure in ALS.

Muscle & nerve·2026
Same author

Strategic Amyotrophic Lateral Sclerosis Australia-Systems Genomics Consortium (SALSA-SGC): cohort profile.

BMJ open·2026
Same author

Integration of Serum Neurofilament Light Chain and Cortical Dysfunction Improves Diagnostic Accuracy in ALS.

Annals of clinical and translational neurology·2026
Same author

Supporting gastrostomy decision-making in motor neurone disease (MND): an Australian survey of healthcare professionals' beliefs, practices, and needs.

Neurodegenerative disease management·2026
Same author

Monoallelic POLR3A Variants Cause Early-Onset Peripheral Neuropathy.

Annals of neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Long-term IV immunoglobulin therapy significantly improved muscle strength and function in multifocal motor neuropathy patients. Unlike previous studies, this research found reduced nerve damage and improved conduction blocks with higher IVIg doses.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multifocal motor neuropathy with conduction blocks (MMNCB) is an immune-mediated motor neuropathy.
  • Previous studies on long-term IV immunoglobulin (IVIg) treatment showed improved strength but increased axonal degeneration (AD) and conduction blocks (CB).

Purpose of the Study:

  • To evaluate the long-term clinical and neurophysiological effects of IVIg therapy in MMNCB patients.
  • To assess the impact of a specific IVIg regimen on MMNCB progression and outcomes.

Main Methods:

  • Retrospective analysis of medical records for 10 MMNCB patients.
  • Assessment of muscle strength (MRC score) and functional disability (mRS).
  • Evaluation of conduction blocks (CB) and acute axonal degeneration (AD) over an average follow-up of 7.25 years.
  • Patients received initial IVIg (2g/kg) followed by monthly maintenance therapy.

Related Experiment Videos

Main Results:

  • Significant and sustained improvement in muscle strength and functional disability.
  • Significant reduction in conduction blocks (CB) and axonal degeneration (AD).
  • Evidence of nerve reinnervation observed by the end of the follow-up period.

Conclusions:

  • Long-term IVIg therapy, particularly with higher maintenance doses, improves clinical outcomes and neurophysiological measures in MMNCB.
  • Findings contradict previous reports suggesting neurophysiological deterioration with long-term IVIg.
  • The study highlights the potential benefits of optimized IVIg regimens for managing MMNCB.